These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6729984)

  • 1. Serum cholesterol and triglycerides in childhood nephrotic syndrome in northern Nigeria. A preliminary report.
    Abdurrahman MB; Suvarnabai PC; Aikhionbare HA; Timoszyk J
    Trop Geogr Med; 1984 Mar; 36(1):7-11. PubMed ID: 6729984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein A and high density lipoprotein cholesterol in childhood nephrotic syndrome.
    Agbedana EO; Taylor GO; Folami AO
    East Afr Med J; 1990 Apr; 67(4):279-85. PubMed ID: 2364904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of serum cholesterol in childhood nephrotic syndrome.
    Okoro BA
    East Afr Med J; 1987 Dec; 64(12):845-8. PubMed ID: 3505207
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased high density lipoprotein cholesterol in adult nephrotic syndrome in Nigeria.
    Adigun MO; Agbedana EO; Kadiri S; Taylor GO
    Afr J Med Med Sci; 1999; 28(1-2):97-100. PubMed ID: 12953996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of lipoprotein lipase by plasma from children with the steroid responsive nephrotic syndrome.
    Vermylen C; Levin M; Barratt TM; Muller DP
    Pediatr Res; 1987 Aug; 22(2):197-200. PubMed ID: 3658546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma lipids and lipoprotein-cholesterol distribution in nephrotic syndrome patients during short term high dose steroid treatment.
    Arije A; Erasmus RT; Anjorin SA
    Cent Afr J Med; 1993 Oct; 39(10):211-5. PubMed ID: 8020077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum lipid profile in malnourished Nigerian children in Zaria.
    Akuyam A; Isah HS; Ogala WN
    Niger Postgrad Med J; 2008 Sep; 15(3):192-6. PubMed ID: 18923595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyperlipemia in nephrotic syndrome].
    Walasek L
    Pol Tyg Lek; 1972 Jan; 27(5):189-91. PubMed ID: 4551652
    [No Abstract]   [Full Text] [Related]  

  • 9. Hyperlipidemia in childhood idiopathic nephrotic syndrome during initial remission and relapse.
    Mahmud S; Jahan S; Hossain MM
    Mymensingh Med J; 2011 Jul; 20(3):402-6. PubMed ID: 21804502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serumlipoproteins in children with nephrotic syndrome and chronic renal failure.
    Widhalm K; Singer P; Balzar E
    Artery; 1980; 8(2):191-8. PubMed ID: 7458686
    [No Abstract]   [Full Text] [Related]  

  • 11. Diffusible fraction of cholesterol in serum of patients with nephrotic syndrome.
    Markiewicz K; Lutz W; Walasek L
    Acta Med Pol; 1975; 16(3):151-8. PubMed ID: 1180118
    [No Abstract]   [Full Text] [Related]  

  • 12. Childhood nephrotic syndrome in Enugu, Nigeria.
    Okoro BA; Okafor HU; Nnoli LU
    West Afr J Med; 2000; 19(2):137-41. PubMed ID: 11070750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrotic syndrome in Nigerian children with homozygous sickle cell disease.
    Okoro BA; Okafor HU
    East Afr Med J; 1997 Dec; 74(12):819-21. PubMed ID: 9557431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential role of HMG-CoA reductase inhibitors in pediatric nephrotic syndrome.
    Prescott WA; Streetman DA; Streetman DS
    Ann Pharmacother; 2004 Dec; 38(12):2105-14. PubMed ID: 15507504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in proteinuria attenuates hyperlipidemia in the nephrotic syndrome.
    Kaysen GA; Davies RW
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S75-9. PubMed ID: 16989070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of non-HDL fraction to oxidation in experimental nephrotic syndrome.
    Dirican M; Taş S; Sarandöl E; Tokullugil HA
    Kobe J Med Sci; 1998 Dec; 44(5-6):235-45. PubMed ID: 10401226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of gemfibrozil on hyperlipidemia in children with persistent nephrotic syndrome.
    Büyükçelik M; Anarat A; Bayazit AK; Noyan A; Ozel A; Anarat R; Aydingülü H; Dikmen N
    Turk J Pediatr; 2002; 44(1):40-4. PubMed ID: 11858378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum-cholesterol-binding reserve in patients with the nephrotic syndrome.
    Perez GO; Levine S; Gomez E; Hsia SL
    Nephron; 1979; 24(3):146-9. PubMed ID: 492425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased antioxidant activity in hypercholesterolemic children with nephrotic syndrome.
    Zachwieja J; Bobkowski W; Dobrowolska-Zachwieja A; Zaniew M; Maciejewski J
    Med Sci Monit; 2003 Jun; 9(6):CR235-9. PubMed ID: 12824952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum lipid levels in children and teenagers from Concepción, Chile].
    Casanueva V; Cid X; Chiang MT; Román R; Milos C; Reyes M; Venegas H; Casanueva P
    Rev Med Chil; 1996 Dec; 124(12):1453-61. PubMed ID: 9334479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.